These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17850733)

  • 1. Clinical research and drug development in Latin America: weighing the pros and cons, talking about the future.
    Rodrigues DG
    J Investig Med; 2007 Jul; 55(5):223-9. PubMed ID: 17850733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who should pay for the continuity of post-trial health care treatments?
    Iunes R; Uribe MV; Torres JB; Garcia MM; Alvares-Teodoro J; de Assis Acurcio F; Junior AAG
    Int J Equity Health; 2019 Jun; 18(1):26. PubMed ID: 31155007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects.
    Homedes N; Ugalde A
    Salud Colect; 2016; 12(3):317-345. PubMed ID: 28414846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of drug promotion.
    Silverman M
    Int J Health Serv; 1977; 7(2):157-66. PubMed ID: 856741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials for genetic diseases in Latin America.
    Poswar FO; da Silva LP; Zambrano MB; Pedrini DB; Saute JAM; Giugliani R
    Am J Med Genet C Semin Med Genet; 2021 Sep; 187(3):381-387. PubMed ID: 34480410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical companies as sponsors of clinical trials--advantages and limitations].
    Reis LL
    Rev Port Cardiol; 1992 Apr; 11(4):333-8. PubMed ID: 1632988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress and challenges of clinical trials registration in Latin America and the Caribbean's].
    Reveiz L; Saenz C; Murasaki RT; Cuervo LG; Ramalho L
    Rev Peru Med Exp Salud Publica; 2011 Dec; 28(4):676-81. PubMed ID: 22241267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between intellectual property and drug regulatory systems: global perspectives.
    Madden EA
    IDrugs; 2007 Feb; 10(2):116-20. PubMed ID: 17285464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of neuromuscular diseases and spinal muscular atrophy in Latin America.
    Monges S; Rosa AL
    Gene Ther; 2017 Sep; 24(9):578-580. PubMed ID: 28753203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patents for critical pharmaceuticals: the AZT case.
    Ackiron E
    Am J Law Med; 1991; 17(1-2):145-80. PubMed ID: 1877607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.